Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.

Alexander L Miller1, Catherine S Hall, Robert W Buchanan

  • 1Department of Psychiatry, The University of Texas Health Science Center at San Antonio, MC 7792, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900, USA. millera@uthscsa.edu

The Journal of Clinical Psychiatry
|May 4, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

Neuropsychiatric disease and treatment·2026
Same author

Is It Time for a Universal Outcome Measure to Deliver on the Promises of Interventional Psychiatry?

The American journal of psychiatry·2026
Same author

Derivation of an updated brief multivariable prediction model to detect panic-related anxiety in emergency department patients with cardiopulmonary complaints.

Frontiers in psychiatry·2026
Same author

Assessing symptom severity in patients with markedly treatment-resistant depression: Insights from the RECOVER trial.

Journal of affective disorders·2026
Same author

Factors associated with interpersonal retraumatization in children and adolescents: A prospective study.

Psychiatry research·2025
Same author

The trajectory of symptom change over the course of transcranial magnetic stimulation for major depressive disorder.

Brain stimulation·2025
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles
This summary is machine-generated.

The Texas Medication Algorithm Project updated its schizophrenia treatment guidelines in 2003. New recommendations include ziprasidone and aripiprazole as first-line antipsychotics, reducing steps before clozapine use.

Area of Science:

  • Psychiatry and Pharmacology
  • Clinical Guidelines Development
  • Schizophrenia Treatment

Background:

  • The Texas Medication Algorithm Project (TMAP) provides evidence-based guidelines for treating schizophrenia, bipolar disorder, and major depressive disorder.
  • Previous antipsychotic algorithm for schizophrenia was last updated in 1999.
  • This article details 2002-2003 updates to the TMAP antipsychotic algorithm for schizophrenia.

Framework:

  • Literature review and expert presentations on key treatment questions.
  • Data rated using Agency for Healthcare Research and Quality criteria.
  • Consensus-based recommendations developed through expert conference and electronic communication.

Implementation:

  • Updated algorithm includes ziprasidone and aripiprazole as first-line antipsychotic agents.

Related Experiment Videos

  • Reduced the number of treatment stages required before considering clozapine.
  • First-generation antipsychotics included but not as initial treatment choices.

    • Implications:

    • Revised algorithm prioritizes antipsychotic monotherapy over combination therapy for non-responders.
    • Highlights the need for further research on optimal medication sequencing and types for schizophrenia.
    • Facilitates standardized, evidence-based care for schizophrenia patients in public health settings.